Molecular determinants of disease in coxsackievirus B1 murine infection

Journal of Medical Virology

Volumn 83, Issue 9, 2011, Pages 1571-1581

  Cifuente, Javier O ^a   Ferrer, María F ^a   de Giusti, Carolina Jaquenod ^a   Song, Wen Chao ^b   Romanowski, Víctor ^a   Hafenstein, Susan L ^c   Gómez, Ricardo M ^a  

^a Inst de Biotecnología Y Biología Molecular IBBM   (Argentina)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

CAR; DAF; Mice; Myocarditis; Pancreatitis

Indexed keywords

COXSACKIE VIRUS B 1N PROTEIN; COXSACKIE VIRUS B 1NM PROTEIN; DECAY ACCELERATING FACTOR; DECAY ACCELERATING FACTOR 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; CVB1NM GENE; HELA CELL; HEMAGGLUTINATION; INOCULATION; MALE; MOLECULAR DIAGNOSIS; MOUSE; MYOCARDITIS; NONHUMAN; PANCREATITIS; PICHIA PASTORIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERE COMBINED IMMUNODEFICIENCY; SINGLE BLIND PROCEDURE; VIROGENESIS; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD55; BASE SEQUENCE; BINDING SITES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; MALE; MICE; MICE, INBRED C3H; MUTATION; RECEPTORS, VIRUS; SEQUENCE ANALYSIS, DNA; VIRAL PLAQUE ASSAY;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS B; MURINAE; MUS;

EID: 79960121662     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22133     Document Type: Article

References (74)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
2. Beck MA, Levander OA, Handy J. 2003. Selenium deficiency and viral infection. J Nutr 133: 1463S-1467S.
3. Belnap DM, McDermott BM, Jr, Filman DJ, Cheng N, Trus BL, Zuccola HJ, Racaniello VR, Hogle JM, Steven AC. 2000. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci USA 97: 73-78.
4. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69: 1903-1936.
5. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1323.
6. Bhella D, Goodfellow IG, Roversi P, Pettigrew D, Chaudhry Y, Evans DJ, Lea SM. 2004. The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55). J Biol Chem 279: 8325-8332.
7. Bopegamage S, Kovacova J, Vargova A, Motusova J, Petrovicova A, Benkovicova M, Gomolcak P, Bakkers J, van Kuppeveld F, Melchers WJ, Galama JM. 2005. Coxsackie B virus infection of mice: Inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86: 3271-3280.
8. Cameron-Wilson CL, Pandolfino YA, Zhang HY, Pozzeto B, Archard LC. 1998. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: Assessment of candidate mutations by analysis of a revertant to cardiovirulence. Clin Diagn Virol 9: 99-105.
9. Chapman NM, Ramsingh AI, Tracy S. 1997. Genetics of coxsackievirus virulence. Curr Top Microbiol Immunol 223: 227-258.
10. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31: 3497-3500.
11. Cihakova D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. 2004. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol Med 102: 175-193.
12. Colonno RJ, Condra JH, Mizutani S, Callahan PL, Davies ME, Murcko MA. 1988. Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci USA 85: 5449-5453.
13. Coyne CB, Bergelson JM. 2006. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124: 119-131.
14. Curry S, Chow M, Hogle JM. 1996. The poliovirus 135S particle is infectious. J Virol 70: 7125-7131.
15. del Angel RM, Papavassiliou AG, Fernandez-Tomas C, Silverstein SJ, Racaniello VR. 1989. Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci USA 86: 8299-8303.
16. Domingo E, Martin V, Perales C, Grande-Pérez A, García-Arriaza J, Arias A. 2006. Viruses as quasispecies: Biological implications. Curr Top Microbiol Immunol 299: 51-82.
17. Dunn JJ, Chapman NM, Tracy S, Romero JR. 2000. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: Localization to the 5' nontranslated region. J Virol 74: 4787-4794.
18. Dunn JJ, Bradrick SS, Chapman NM, Tracy SM, Romero JR. 2003. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. J Infect Dis 187: 1552-1561.
19. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. 2005. Virus Taxonomy: VIIIth Report of the International Committee on Taxonomy of Viruses: Elsevier Academic Press.
20. Feldman AM, McNamara D. 2000. Myocarditis. N Engl J Med 343: 1388-1398.
21. Filman DJ, Wien MW, Cunningham JA, Bergelson JM, Hogle JM. 1998. Structure determination of echovirus 1. Acta Crystallogr D Biol Crystallogr 54: 1261-1272.
22. Fry EE, Knowles NJ, Newman JW, Wilsden G, Rao Z, King AM, Stuart DI. 2003. Crystal structure of Swine vesicular disease virus and implications for host adaptation. J Virol 77: 5475-5486.
23. Gomez RM, Rinehart JE, Wollmann R, Roos RP. 1996. Theiler's murine encephalomyelitis virus-induced cardiac and skeletal muscle disease. J Virol 70: 8926-8933.
24. Hadfield AT, Lee W, Zhao R, Oliveira MA, Minor I, Rueckert RR, Rossmann MG. 1997. The refined structure of human rhinovirus 16 at 2.15 A resolution: Implications for the viral life cycle. Structure 5: 427-441.
25. Hafenstein S, Bowman VD, Chipman PR, Bator Kelly CM, Lin F, Medof ME, Rossmann MG. 2007. Interaction of decay-accelerating factor with coxsackievirus B3. J Virol 81: 12927-12935.
26. Harvala H, Kalimo H, Dahllund L, Santti J, Hughes P, Hyypia T, Stanway G. 2002. Mapping of tissue tropism determinants in coxsackievirus genomes. J Gen Virol 83: 1697-1706.
27. Harvala H, Kalimo H, Bergelson J, Stanway G, Hyypia T. 2005. Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J Gen Virol 86: 1897-1907.
28. He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, Kuhn RJ, Anderson CW, Freimuth P, Rossmann MG. 2001. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 8: 874-878.
29. He Y, Lin F, Chipman PR, Bator CM, Baker TS, Shoham M, Kuhn RJ, Medof ME, Rossmann MG. 2002. Structure of decay-accelerating factor bound to echovirus 7: A virus-receptor complex. Proc Natl Acad Sci USA 99: 10325-10329.
30. Hellen CU, Pestova TV, Litterst M, Wimmer E. 1994. The cellular polypeptide p57 (pyrimidine tract-binding protein) binds to multiple sites in the poliovirus 5' nontranslated region. J Virol 68: 941-950.
31. Hendry E, Hatanaka H, Fry E, Smyth M, Tate J, Stanway G, Santti J, Maaronen M, Hyypia T, Stuart D. 1999. The crystal structure of coxsackievirus A9: New insights into the uncoating mechanisms of enteroviruses. Structure 7: 1527-1538.
32. Hogle JM, Chow M, Filman DJ. 1985. Three-dimensional structure of poliovirus at 2.9A resolution. Science 229: 1358-1365.
33. Hufnagel G, Chapman N, Tracy S. 1995. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome. Eur Heart J 16: 18-19.
34. Hyypia T, Kallajoki M, Maaronen M, Stanway G, Kandolf R, Auvinen P, Kalimo H. 1993. Pathogenetic differences between coxsackie A and B virus infections in newborn mice. Virus Res 27: 71-78.
35. Iizuka N, Kuge S, Nomoto A. 1987. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology 156: 64-73.
36. Iizuka N, Yonekawa H, Nomoto A. 1991. Nucleotide sequences important for translation initiation of enterovirus RNA. J Virol 65: 4867-4873.
37. Kallewaard NL, Zhang L, Chen JW, Guttenberg M, Sanchez MD, Bergelson JM. 2009. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 6: 91-98.
38. Katpally U, Smith TJ. 2007. Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus. J Virol 81: 6307-6315.
39. Kim KS, Hufnagel G, Chapman NM, Tracy S. 2001. The group B coxsackieviruses and myocarditis. Rev Med Virol 11: 355-368.
40. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70: 7811-7818.
41. Kolatkar PR, Bella J, Olson NH, Bator CM, Baker TS, Rossmann MG. 1999. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J 18: 6249-6259.
42. Lee C, Maull E, Chapman N, Tracy S, Gauntt C. 1997. Genomic regions of coxsackievirus B3 associated with cardiovirulence. J Med Virol 52: 341-347.
43. Luo M, Vriend G, Kamer G, Minor I, Arnold E, Rossmann MG, Boege U, Scraba DG, Duke GM, Palmenberg AC. 1987. The atomic structure of Mengo virus at 3.0 A resolution. Science 235: 182-191.
44. Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM. 2005. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 79: 655-660.
45. MMWR. 2008. Increased detections and severe neonatal disease associated with coxsackievirus B1 infection-United States, 2007. Morb Mortal Wkly Rep 57: 553-556.
46. MMWR. 2010. Increased detections and severe neonatal disease associated with coxsackievirus B1 infection-United States, 2007. Morb Mortal Wkly Rep 59: 1577-1580.
47. Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG. 1995. The structure of coxsackievirus B3 at 3.5A resolution. Structure 3: 653-667.
48. Oberste MS. 2008. Comparative genomics of the coxsackie B viruses and related enteroviruses. Curr Top Microbiol Immunol 323: 33-47.
49. Olson NH, Kolatkar PR, Oliveira MA, Cheng RH, Greve JM, McClelland A, Baker TS, Rossmann MG. 1993. Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci USA 90: 507-511.
50. Orthopoulos G, Triantafilou K, Triantafilou M. 2004. Coxsackie B viruses use multiple receptors to infect human cardiac cells. J Med Virol 74: 291-299.
51. Pallansch MA, Roos RP. 2001. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, Knipe DM, editors. Virology. Philadelphia, PA: Lippincott Williams & Wilkins, pp 589-630.
52. Papadopoulos JS, Agarwala R. 2007. COBALT: Constraint-based alignment tool for multiple protein sequences. Bioinformatics 23: 1073-1079.
53. Pasch A, Kupper JH, Wolde A, Kandolf R, Selinka HC. 1999. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J Gen Virol 80: 3153-3158.
54. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
55. Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW. 1998. Characterization of echoviruses that bind decay accelerating factor (CD55): Evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 79: 1707-1713.
56. Powell RM, Ward T, Goodfellow I, Almond JW, Evans DJ. 1999. Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: Implications for the evolution of a DAF-binding phenotype. J Gen Virol 80: 3145-3152.
57. Rinehart JE, Gomez RM, Roos RP. 1997. Molecular determinants for virulence in coxsackievirus B1 infection. J Virol 71: 3986-3991.
58. Rossmann MG. 1994. Viral cell recognition and entry. Protein Sci 3: 1712-1725.
59. Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht HJ, Johnson JE, Kamer G, Luo M, Mosser AG, Rueckert RR, Sherry B, Vriend G. 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317: 145-153.
60. Rossmann MG, He Y, Kuhn RJ. 2002. Picornavirus-receptor interactions. Trends Microbiol 10: 324-331.
61. Sanner MF, Olson AJ, Spehner JC. 1996. Reduced surface: An efficient way to compute molecular surfaces. Biopolymers 38: 305-320.
62. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69: 3873-3877.
63. Shieh JT, Bergelson JM. 2002. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J Virol 76: 9474-9480.
64. Sonenberg N, Dever TE. 2003. Eukaryotic translation initiation factors and regulators. Curr Opinion Struct Biol 13: 56-63.
65. Spiller OB, Goodfellow IG, Evans DJ, Almond JW, Morgan BP. 2000. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. J Infect Dis 181: 340-343.
66. Stadnick E, Dan M, Sadeghi A, Chantler JK. 2004. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3. J Virol 78: 13987-14002.
67. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
68. Tomko RP, Xu R, Philipson L. 1997. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94: 3352-3356.
69. Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. 2000. Group B coxsackievirus myocarditis and pancreatitis: Connection between viral virulence phenotypes in mice. J Med Virol 62: 70-81.
70. Verdaguer N, Blaas D, Fita I. 2000. Structure of human rhinovirus serotype 2 (HRV2). J Mol Biol 300: 1179-1194.
71. Whitton JL, Cornell CT, Feuer R. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 3: 765-776.
72. Wikswo ME, Khetsuriani N, Fowlkes AL, Zheng X, Penaranda S, Verma N, Shulman ST, Sircar K, Robinson CC, Schmidt T, Schnurr D, Oberste MS. 2009. Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007-2008. Clin Infect Dis 49: e44-e51.
73. Xiao C, Rossmann MG. 2007. Interpretation of electron density with stereographic roadmap projections. J Struct Biol 158: 182-187.
74. Zhong Z, Li X, Zhao W, Tong L, Liu J, Wu S, Lin L, Zhang Z, Tian Y, Zhang F. 2008. Mutations at nucleotides 573 and 579 within 5'-untranslated region augment the virulence of coxsackievirus B1. Virus Res 135: 255-259.